Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
Source: Bioprocess Online
In this third installment of our cell & gene therapy manufacturing miniseries, Erin Harris and Matt Pillar sit down with Orchard Therapeutics CEO Dr. Bobby Gaspar. An update on the company's pipeline progress gives way to an in-depth discussion on the process challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders.
This website uses cookies to ensure you get the best experience on our website. Learn more